410 related articles for article (PubMed ID: 8424682)
1. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
Rydzewski A; Castellino FJ
Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
[TBL] [Abstract][Full Text] [Related]
2. The construction and expression of chimeric urokinase-type plasminogen activator genes containing kringle domains of human plasminogen.
Boutaud A; Castellino FJ
Arch Biochem Biophys; 1993 Jun; 303(2):222-30. PubMed ID: 8512311
[TBL] [Abstract][Full Text] [Related]
3. Role of tryptophan-63 of the kringle 2 domain of tissue-type plasminogen activator in its thermal stability, folding, and ligand binding properties.
Chang Y; Zajicek J; Castellino FJ
Biochemistry; 1997 Jun; 36(25):7652-63. PubMed ID: 9201906
[TBL] [Abstract][Full Text] [Related]
4. Role of tryptophan-74 of the recombinant kringle 2 domain of tissue-type plasminogen activator in its omega-amino acid binding properties.
De Serrano VS; Castellino FJ
Biochemistry; 1992 Apr; 31(13):3326-35. PubMed ID: 1554717
[TBL] [Abstract][Full Text] [Related]
5. Hybrid molecules: insights into plasminogen activator function.
Runge MS; Bode C; Haber E; Quertermous T
Mol Biol Med; 1991 Apr; 8(2):245-55. PubMed ID: 1806766
[TBL] [Abstract][Full Text] [Related]
6. Spatial orientation of tissue-type plasminogen activator bound at the melanoma cell surface.
Bizik J; Trancikova D; Felnerova D; Verheijen JH; Vaheri A
Biochem Biophys Res Commun; 1997 Oct; 239(1):322-8. PubMed ID: 9345318
[TBL] [Abstract][Full Text] [Related]
7. Specific anionic residues of the recombinant kringle 2 domain of tissue-type plasminogen activator that are responsible for stabilization of its interaction with omega-amino acid ligands.
De Serrano VS; Castellino FJ
Biochemistry; 1993 Apr; 32(14):3540-8. PubMed ID: 8385482
[TBL] [Abstract][Full Text] [Related]
8. The cationic locus on the recombinant kringle 2 domain of tissue-type plasminogen activator that stabilizes its interaction with omega-amino acids.
De Serrano VS; Castellino FJ
Biochemistry; 1992 Dec; 31(47):11698-706. PubMed ID: 1332768
[TBL] [Abstract][Full Text] [Related]
9. Role of the strictly conserved tryptophan-25 residue in the stabilization of the structure and in the ligand binding properties of the kringle 2 domain of tissue-type plasminogen activator.
De Serrano VS; Castellino FJ
Biochemistry; 1994 Feb; 33(6):1340-4. PubMed ID: 8312251
[TBL] [Abstract][Full Text] [Related]
10. Direct identification of lysine-33 as the principal cationic center of the omega-amino acid binding site of the recombinant kringle 2 domain of tissue-type plasminogen activator.
De Serrano VS; Sehl LC; Castellino FJ
Arch Biochem Biophys; 1992 Jan; 292(1):206-12. PubMed ID: 1309292
[TBL] [Abstract][Full Text] [Related]
11. Stimulation by fibrinogen of the amidolytic activity of single-chain tissue plasminogen activator.
Urano T; deSerrano VS; Urano S; Castellino FJ
Arch Biochem Biophys; 1989 Apr; 270(1):356-62. PubMed ID: 2494944
[TBL] [Abstract][Full Text] [Related]
12. Characterization of human tissue-type plasminogen activator variants with amino acid mutations in the kringle 1 domain.
Ikenaka Y; Yajima K; Yahara H; Maruyama H; Matsumoto K; Okada K; Ueshima S; Matsuo O
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):381-7. PubMed ID: 1330023
[TBL] [Abstract][Full Text] [Related]
13. Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR.
Marti DN; Hu CK; An SS; von Haller P; Schaller J; Llinás M
Biochemistry; 1997 Sep; 36(39):11591-604. PubMed ID: 9305949
[TBL] [Abstract][Full Text] [Related]
14. A refined kinetic analysis of plasminogen activation by recombinant bovine tissue-type plasminogen activator indicates two interconvertible activator forms.
Johnsen LB; Ravn P; Berglund L; Petersen TE; Rasmussen LK; Heegaard CW; Rasmussen JT; Benfeldt C; Fedosov SN
Biochemistry; 1998 Sep; 37(36):12631-9. PubMed ID: 9730836
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the intrinsic fibrinolytic properties of pro-urokinase through a study of plasmin-resistant mutant forms produced by site-specific mutagenesis of lysine(158).
Gurewich V; Pannell R; Broeze RJ; Mao J
J Clin Invest; 1988 Dec; 82(6):1956-62. PubMed ID: 2974047
[TBL] [Abstract][Full Text] [Related]
16. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
[TBL] [Abstract][Full Text] [Related]
17. Involvement of tyrosine-76 of the kringle 2 domain of tissue-type plasminogen activator in its thermal stability and its omega-amino acid ligand binding site.
De Serrano VS; Castellino FJ
Biochemistry; 1994 Mar; 33(12):3509-14. PubMed ID: 8142348
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and biological properties of a recombinant tissue-type plasminogen activator derived from the rat JMI-229 cell line.
Lijnen HR; Webb PD; Van Hoef B; De Cock F; Stassen JM; Prior SD; Collen D
Thromb Haemost; 1992 Feb; 67(2):239-47. PubMed ID: 1621244
[TBL] [Abstract][Full Text] [Related]
19. Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators.
Urano S; Metzger AR; Castellino FJ
Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2568-71. PubMed ID: 2523073
[TBL] [Abstract][Full Text] [Related]
20. The 2.3 A crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator.
Lamba D; Bauer M; Huber R; Fischer S; Rudolph R; Kohnert U; Bode W
J Mol Biol; 1996 Apr; 258(1):117-35. PubMed ID: 8613982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
